Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

DiaVacs's Immunotherapy Product for Treatment of Type 1 Diabetes Receives Orphan Drug Status Designation from the FDA

PR Newswire January 6, 2014

Ajinomoto Althea Inc. Appoints J. David Enloe Jr. as President and Chief Executive Officer

PR Newswire January 6, 2014

The Leukemia & Lymphoma Society of Canada shines the spotlight on cancer cures during the whole month of February with "Someday is Today"

Canada NewsWire January 6, 2014

Research and Markets: EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2022

Business Wire January 6, 2014

Trovagene and US Oncology Research Collaborate on a Prospective Study for Urine-based KRAS Testing in Patients with Metastatic Pancreatic Cancer

PR Newswire January 6, 2014

2014 Biotech China-Your Only Chance to Join Full-Scale International Biotech Fair in China

Business Wire January 6, 2014

New Roads Ahead for Android and the Open Automotive Alliance

Business Wire January 6, 2014

New Clinical Data on Day 3 Embryo Transfers Using Eeva(TM) Technology Presented at the Association of Clinical Embryologists 2014 Conference

PR Newswire January 6, 2014

Astellas To Form Strategic Partnership With ClearPath To Build Vaccine Portfolio

PR Newswire January 6, 2014

PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from NICE

PR Newswire January 6, 2014

Life-extending Metastatic Breast Cancer Treatment Now Available in the Republic of Ireland

PR Newswire January 5, 2014

Innovative Metastatic Breast Cancer Treatment Halaven® (Eribulin) Recieves Reimbursement Approval in the Czech Republic

PR Newswire January 5, 2014

Bird flu in China killed 8,500 chickens in December

UPI January 4, 2014

Governor Corbett Opens 2014 Pennsylvania Farm Show

PR Newswire January 4, 2014

Pennsylvania Agriculture Secretary Warns Low Temperatures Can Cause Cold Stress in Livestock, Pets

PR Newswire January 3, 2014

Prothena to be Added to NASDAQ Biotechnology Index and NASDAQ Global Select Market

Thomson Reuters ONE December 30, 2013

Sobi to temporarily withdraw New Drug Application for Orfadin® oral suspension in the US

Thomson Reuters ONE December 27, 2013

Cryo-Save Group N.V. - acquisition of the commercial activities of Salveo Biotechnology

Thomson Reuters ONE December 24, 2013

Fujitsu Expands Lineup of Akisai Food and Agriculture Cloud Services

JCN Newswire December 24, 2013

BUREAU VERITAS: acquisition of Maxxam, Canada's market leader in petroleum, environmental, food and DNA analytical services

Thomson Reuters ONE December 21, 2013